• 1. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 2. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 3. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 4. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 5. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Methoxybenzoic acids and derivatives

Methyl 3-bromo-4-methoxybenzoate (CAS No. 35450-37-4): A Versatile Intermediate in Modern Pharmaceutical Synthesis

Methyl 3-bromo-4-methoxybenzoate (CAS No. 35450-37-4) is a significant intermediate in the field of organic synthesis, particularly in the pharmaceutical industry. This compound, characterized by its bromine and methoxy substituents on a benzoic acid backbone, has garnered considerable attention due to its utility in the development of various bioactive molecules. The structural features of Methyl 3-bromo-4-methoxybenzoate make it a valuable building block for synthesizing complex pharmacophores, which are essential for drug discovery and development.

The chemical structure of Methyl 3-bromo-4-methoxybenzoate consists of a benzene ring substituted with a bromine atom at the 3-position and a methoxy group at the 4-position, along with a methyl ester group at the carboxyl position. This arrangement provides multiple reactive sites that can be selectively modified through various chemical transformations. The presence of the bromine atom, in particular, makes this compound amenable to cross-coupling reactions such as Suzuki-Miyaura, Stille, and Buchwald-Hartwig couplings, which are widely employed in the construction of biaryl structures.

In recent years, there has been a surge in research focused on developing novel therapeutic agents targeting various diseases. Among these, cancer remains a major global health challenge. The development of effective anticancer drugs often relies on the synthesis of complex molecular architectures that can interact with biological targets with high specificity and affinity. Methyl 3-bromo-4-methoxybenzoate has emerged as a key intermediate in this endeavor, facilitating the synthesis of molecules that exhibit potent anticancer activity.

One notable application of Methyl 3-bromo-4-methoxybenzoate is in the synthesis of kinase inhibitors. Kinases are enzymes that play crucial roles in cell signaling pathways, and their dysregulation is often associated with cancer and other diseases. By incorporating the benzoate scaffold into kinase inhibitors, researchers can design molecules that selectively inhibit aberrant signaling pathways. The bromine and methoxy substituents on the benzene ring provide opportunities for further functionalization, allowing for the creation of highly tailored inhibitors with improved pharmacological properties.

Recent studies have highlighted the utility of Methyl 3-bromo-4-methoxybenzoate in the development of small molecule inhibitors targeting Bruton's tyrosine kinase (BTK). BTK is a key enzyme involved in B-cell signaling, and its inhibition has been shown to be effective in treating certain types of leukemia and autoimmune disorders. Researchers have leveraged the reactivity of the bromine atom in Methyl 3-bromo-4-methoxybenzoate to construct BTK inhibitors that exhibit significant therapeutic potential. These inhibitors have undergone extensive preclinical evaluation and have shown promising results in early clinical trials.

The versatility of Methyl 3-bromo-4-methoxybenzoate extends beyond its role in anticancer drug development. It has also been utilized in the synthesis of antimicrobial agents. The growing threat of antibiotic-resistant bacteria necessitates the discovery of novel antimicrobial compounds. By modifying the structure of Methyl 3-bromo-4-methoxybenzoate, chemists have been able to generate derivatives with enhanced antimicrobial activity against resistant strains.

In addition to its pharmaceutical applications, Methyl 3-bromo-4-methoxybenzoate finds use in materials science and agrochemicals. Its unique structural features make it a valuable precursor for synthesizing dyes, pigments, and specialty chemicals. Furthermore, its derivatives have been explored as potential intermediates in the development of new pesticides and herbicides, contributing to sustainable agricultural practices.

The synthesis of Methyl 3-bromo-4-methoxybenzoate typically involves bromination and methylation reactions on commercially available benzoic acid derivatives. These reactions are well-established and can be performed under mild conditions using standard reagents and catalysts. The high yield and purity obtained from these synthetic routes make Methyl 3-bromo-4-methoxybenzoate an attractive choice for industrial applications.

The future prospects for Methyl 3-bromo-4-methoxybenzoate are promising, given its broad utility across multiple domains. As research continues to uncover new therapeutic targets and synthetic methodologies, this compound is expected to play an increasingly important role in drug discovery and development. Furthermore, advancements in green chemistry principles may lead to more sustainable synthetic routes for producing high-quality batches of this valuable intermediate.

• 93-44-7(naphthalen-2-yl benzoate)
• 94-18-8(Benzyl 4-\u200bHydroxybenzoate(Benzyl Paraben))
• 93-99-2(Phenyl benzoate)
• 91-52-1(2,4-Dimethoxybenzoic acid)
• 93-58-3(Methyl benzoate)
• 94-01-9(1,3-Dibenzoyloxybenzene)
• 94-13-3(Propylparaben)
• 87-28-5(Glycol salicylate)
• 50-78-2(Aspirin)
• 93-07-2(Veratric acid)